These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36530095)

  • 21. There is reduced immunohistochemical staining of placental aromatase in severe neonatal opioid withdrawal syndrome.
    Townsel C; Odukoya E; Rae J; Thomas D
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9227-9233. PubMed ID: 34978244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eat, Sleep, Console and Adjunctive Buprenorphine Improved Outcomes in Neonatal Opioid Withdrawal Syndrome.
    Hein S; Clouser B; Tamim MM; Lockett D; Brauer K; Cooper L
    Adv Neonatal Care; 2021 Feb; 21(1):41-48. PubMed ID: 33278102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of In-utero Exposure to Selective Serotonin Reuptake Inhibitors and Opioids on Neonatal Opioid Withdrawal Syndrome.
    Bhatt-Mehta V; Richards J; Sturza J; Schumacher RE
    J Addict Med; 2019; 13(3):227-234. PubMed ID: 30489344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome.
    Merhar SL; Ounpraseuth S; Devlin LA; Poindexter BB; Young LW; Berkey SD; Crowley M; Czynski AJ; Kiefer AS; Whalen BL; Das A; Fuller JF; Higgins RD; Thombre V; Lester BM; Smith PB; Newman S; Sánchez PJ; Smith MC; Simon AE;
    Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33632932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial.
    Brown MS; Hayes MJ; Thornton LM
    J Perinatol; 2015 Apr; 35(4):278-83. PubMed ID: 25357093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphine vs Methadone Treatment for Infants with Neonatal Abstinence Syndrome.
    Tolia VN; Murthy K; Bennett MM; Greenberg RG; Benjamin DK; Smith PB; Clark RH
    J Pediatr; 2018 Dec; 203():185-189. PubMed ID: 30220442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal Opioid Withdrawal Syndrome Treatment Guidelines and Birth Hospital Utilization.
    Hahn PD; Graham DA; Ozonoff A; Milliren CE
    Pediatrics; 2024 Jul; 154(1):. PubMed ID: 38899388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome.
    Wachman EM; Newby PK; Vreeland J; Byun J; Bonzagni A; Bauchner H; Philipp BL
    J Addict Med; 2011 Dec; 5(4):293-9. PubMed ID: 21857233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
    Young ME; Hager SJ; Spurlock D
    Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S162-7. PubMed ID: 26582303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
    Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
    Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal: A Post Hoc Subgroup Analysis of the ESC-NOW Randomized Clinical Trial.
    Devlin LA; Hu Z; Merhar SL; Ounpraseuth ST; Simon AE; Lee JY; Das A; Crawford MM; Greenberg RG; Smith PB; Higgins RD; Walsh MC; Rice W; Paul DA; Maxwell JR; Fung CM; Wright T; Ross J; McAllister JM; Crowley M; Shaikh SK; Christ L; Brown J; Riccio J; Wong Ramsey K; Braswell EF; Tucker L; McAlmon K; Dummula K; Weiner J; White JR; Newman S; Snowden JN; Young LW;
    JAMA Pediatr; 2024 Jun; 178(6):525-532. PubMed ID: 38619854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Associated With the Need for Pharmacological Management of Neonatal Opioid Withdrawal Syndrome.
    Scott LF; Guilfoy V; Duwve JM; Rawl SM
    Adv Neonatal Care; 2020 Oct; 20(5):364-373. PubMed ID: 32868586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
    Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
    Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
    Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of naltrexone in treating opioid use disorder in pregnancy.
    Towers CV; Katz E; Weitz B; Visconti K
    Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buprenorphine pharmacotherapy for the management of neonatal abstinence syndrome in methadone-exposed neonates.
    Taleghani AA; Isemann BT; Rice WR; Ward LP; Wedig KE; Akinbi HT
    Paediatr Neonatal Pain; 2019 Dec; 1(2):33-38. PubMed ID: 35548374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal Buprenorphine/Naloxone or Methadone Use on Neonatal Outcomes in Michigan.
    Goshgarian G; Jawad R; O'Brien L; Muterspaugh R; Zikos D; Ezhuthachan S; Newman C; Hsu CD; Bailey B; Ragina N
    Cureus; 2022 Aug; 14(8):e27790. PubMed ID: 36106254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Avoiding NICU Transfers for Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS): A Quality Improvement Initiative to Manage NOWS on the Mother-baby Unit.
    Spence K; Boedeker R; Harhausen M; Kaushal G; Buchanan P; Josephsen J
    J Addict Med; 2020; 14(5):401-408. PubMed ID: 31972766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric Hospital Readmissions for Infants With Neonatal Opioid Withdrawal Syndrome, 2016-2019.
    Milliren CE; Melvin P; Ozonoff A
    Hosp Pediatr; 2021 Sep; 11(9):979-988. PubMed ID: 34417200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of polysubstance exposure on neonatal outcomes for infants with intrauterine opioid exposure.
    McDaniel CE; Test M; Deodhar P; Jennings R; Bove J; Carlin K
    J Perinatol; 2020 Oct; 40(10):1489-1496. PubMed ID: 32641774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.